|
Name |
Orlandin
|
Molecular Formula | C22H18O8 | |
IUPAC Name* |
7-hydroxy-8-(7-hydroxy-4-methoxy-5-methyl-2-oxochromen-8-yl)-4-methoxy-5-methylchromen-2-one
|
|
SMILES |
CC1=CC(=C(C2=C1C(=CC(=O)O2)OC)C3=C(C=C(C4=C3OC(=O)C=C4OC)C)O)O
|
|
InChI |
InChI=1S/C22H18O8/c1-9-5-11(23)19(21-17(9)13(27-3)7-15(25)29-21)20-12(24)6-10(2)18-14(28-4)8-16(26)30-22(18)20/h5-8,23-24H,1-4H3
|
|
InChIKey |
SSGXAFNGBRRLQM-UHFFFAOYSA-N
|
|
Synonyms |
Orlandin; P-orlandin; 69975-77-5; 7-hydroxy-8-(7-hydroxy-4-methoxy-5-methyl-2-oxochromen-8-yl)-4-methoxy-5-methylchromen-2-one; 758G96EL8M; (8,8'-Bi-2H-1-Benzopyran)-2,2'-dione, 7,7'-dihydroxy-4,4'-dimethoxy-5,5'-dimethyl-; 7,7'-dihydroxy-4,4'-dimethoxy-5,5'-dimethyl-2H,2'H-8,8'-bichromene-2,2'-dione; Bis(8,8'-(7-hydroxy-4-methoxy-5-methylcoumarin)); 7,7'-Dihydroxy-4,4'-dimethoxy-5,5'-dimethyl-(8,8'-bi-2H-1-benzopyran)-2,2'-dione; UNII-758G96EL8M; CHEBI:64473; DTXSID20220243; HY-N10194; CS-0372369; Q27133307; 7,7'-DIHYDROXY-4,4'-DIMETHOXY-5,5'-DIMETHYL(8,8'-BI-2H-1-BENZOPYRAN)-2,2'-DIONE
|
|
CAS | 69975-77-5 | |
PubChem CID | 5484238 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 410.4 | ALogp: | 2.9 |
HBD: | 2 | HBA: | 8 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 112.0 | Aromatic Rings: | 4 |
Heavy Atoms: | 30 | QED Weighted: | 0.479 |
Caco-2 Permeability: | -4.953 | MDCK Permeability: | 0.00001710 |
Pgp-inhibitor: | 0.063 | Pgp-substrate: | 0.969 |
Human Intestinal Absorption (HIA): | 0.419 | 20% Bioavailability (F20%): | 0.038 |
30% Bioavailability (F30%): | 0.997 |
Blood-Brain-Barrier Penetration (BBB): | 0.004 | Plasma Protein Binding (PPB): | 77.39% |
Volume Distribution (VD): | 0.622 | Fu: | 19.33% |
CYP1A2-inhibitor: | 0.247 | CYP1A2-substrate: | 0.985 |
CYP2C19-inhibitor: | 0.144 | CYP2C19-substrate: | 0.062 |
CYP2C9-inhibitor: | 0.537 | CYP2C9-substrate: | 0.785 |
CYP2D6-inhibitor: | 0.025 | CYP2D6-substrate: | 0.482 |
CYP3A4-inhibitor: | 0.138 | CYP3A4-substrate: | 0.181 |
Clearance (CL): | 11.4 | Half-life (T1/2): | 0.422 |
hERG Blockers: | 0.015 | Human Hepatotoxicity (H-HT): | 0.881 |
Drug-inuced Liver Injury (DILI): | 0.983 | AMES Toxicity: | 0.188 |
Rat Oral Acute Toxicity: | 0.095 | Maximum Recommended Daily Dose: | 0.839 |
Skin Sensitization: | 0.178 | Carcinogencity: | 0.033 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.601 |
Respiratory Toxicity: | 0.279 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002657 | 0.835 | D06GCK | 0.360 | ||||
ENC000618 | 0.700 | D0FA2O | 0.316 | ||||
ENC003879 | 0.552 | D07MGA | 0.288 | ||||
ENC002002 | 0.424 | D0G4KG | 0.286 | ||||
ENC001411 | 0.423 | D0C1SF | 0.267 | ||||
ENC002134 | 0.420 | D0D4HN | 0.265 | ||||
ENC001501 | 0.404 | D0AZ8C | 0.259 | ||||
ENC000912 | 0.403 | D05HSC | 0.257 | ||||
ENC001770 | 0.400 | D0Y7TS | 0.256 | ||||
ENC006013 | 0.400 | D02LZB | 0.256 |